
CTNM Market Capitalization Overview
Market Cap: $416.07M as of Jan 2, 2026
$416.07M
$87.86M (26.77%)past month
As of Jan 2, 2026, CTNM has a market capitalization of $416.07M. Over the past 30 days, its market cap has increased by 28.27%, while in the last 12 months, it has decreased by -0.35%.
Market capitalization represents the total value of Contineum Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
CTNM Market Cap Formula = Stock Price * Shares Outstanding
The market cap of CTNM helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Contineum Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
CTNM Market Cap Formula = Stock Price * Shares Outstanding
The market cap of CTNM helps investors assess the company's size and compare it with competitors for better investment decisions.
CTNM Market Cap & Key Trends
See Contineum Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in CTNM
Order type
Buy in
Order amount
Est. shares
0 shares
CTNM Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $324.38M | +3.19% |
| Nov 3, 2025 | $314.35M | +1.81% |
| Oct 1, 2025 | $308.75M | -1.43% |
| Sep 2, 2025 | $313.23M | +103.14% |
| Aug 1, 2025 | $154.20M | +54.81% |
| Jul 1, 2025 | $99.61M | -13.09% |
| Jun 2, 2025 | $114.62M | +11.59% |
| May 1, 2025 | $102.71M | -38.54% |
| Apr 1, 2025 | $167.13M | -1.62% |
| Mar 3, 2025 | $169.88M | -29.67% |
| Feb 3, 2025 | $241.54M | -35.29% |
| Jan 2, 2025 | $373.27M | -4.36% |
CTNM End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $416.07M | -0.35% |
| 2025 | $417.54M | +10.56% |
| 2024 | $377.65M | — |
FAQs About Contineum Therapeutics Inc (CTNM) Market Cap
As of Jan 2, 2026, the market capitalization of CTNM is $416.07M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Contineum Therapeutics Inc’s market capitalization has increased by 26.77%, changing from $328.22M to $416.07M as of Jan 2, 2026.
In the last 3 months, Contineum Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Contineum Therapeutics Inc’s market capitalization increased from $377.65M in January to $417.54M in December, reflecting a 10.56% change.
In the past five years, CTNM has had a compound annual growth rate (CAGR) of 5.15% in market capitalization. This means its market cap has grown at an average rate of 5.15% per year.